| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Centre National de la Recherche Scientifique Unité de Recherches Associée 1461 - Université Paris V, Hôpital Necker, 75015 Paris, France
Address all correspondence and requests for reprints to: Françoise Homo-Delarche, Centre National de la Recherche Scientifique Unité de Recherches Associeé 1461, Hôpital Necker, 161, rue de Sèvres, 75743 Paris Cedex 15, France. E-mail: dardenne{at}infobiogen.fr
Because few data were available on glucose homeostasis at the early prediabetic stage in the nonobese diabetic (NOD) mouse, we investigated glycemia, insulinemia, and pancreatic insulin content under basal conditions in both sexes of 4-, 6-, and 8-week-old fed NOD mice, compared with sex- and age-matched fed C57BL/6 mice. We also investigated glucose tolerance in both sexes of fasting 8-week-old NOD and C57BL/6 mice. The main results obtained under basal fed conditions, when comparing both strains, were lower glycemia and higher insulinemia in NOD females at all ages investigated and in NOD males (particularly at 6 weeks of age). Glucose tolerance tests showed that: 1) the blood glucose response to 1 g/kg ip glucose was less sustained in both sexes of 8-week-old NOD mice than in their control counterparts; 2) the blood insulin response to glucose (1 g/kg ip) appeared earlier in both sexes of NOD mice than in sex-matched C57BL/6 mice; 3) an unusual sexual dimorphism existed in NOD mice, compared with controls, with females secreting, in response to glucose, twice as much insulin as males; 4) dose-response studies (16 g/kg glucose) confirmed the lower increase in blood glucose levels in both sexes of NOD mice and their unusual sexual dimorphism in insulin secretion; and 5) glucose tolerance tests in 4- to 8-week-old NOD mice showed that although the sexual dimorphism in insulin secretion was not observed in 4-week-old mice, it was particularly striking at 6 weeks of age. Taken together, these results suggest that ß-cell hyperactivity exists in the NOD mouse at the early prediabetic stage, especially in NOD females.
This article has been cited by other articles:
![]() |
C. Evans-Molina, R. D. Robbins, T. Kono, S. A. Tersey, G. L. Vestermark, C. S. Nunemaker, J. C. Garmey, T. G. Deering, S. R. Keller, B. Maier, et al. Peroxisome Proliferator-Activated Receptor {gamma} Activation Restores Islet Function in Diabetic Mice through Reduction of Endoplasmic Reticulum Stress and Maintenance of Euchromatin Structure Mol. Cell. Biol., April 15, 2009; 29(8): 2053 - 2067. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Antkowiak, S. A. Tersey, J. D. Carter, M. H. Vandsburger, J. L. Nadler, F. H. Epstein, and R. G. Mirmira Noninvasive assessment of pancreatic {beta}-cell function in vivo with manganese-enhanced magnetic resonance imaging Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E573 - E578. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Tarbell, L. Petit, X. Zuo, P. Toy, X. Luo, A. Mqadmi, H. Yang, M. Suthanthiran, S. Mojsov, and R. M. Steinman Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice J. Exp. Med., January 22, 2007; 204(1): 191 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, A. M. Ackermann, G. A. Gusarova, D. Lowe, X. Feng, U. G. Kopsombut, R. H. Costa, and M. Gannon The FoxM1 Transcription Factor Is Required to Maintain Pancreatic {beta}-Cell Mass Mol. Endocrinol., August 1, 2006; 20(8): 1853 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics J. Immunol., March 1, 2005; 174(5): 2746 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khairallah, F. Labarthe, B. Bouchard, G. Danialou, B. J. Petrof, and C. Des Rosiers Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1461 - H1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Castellani, A. M. Goto, and A. J. Lusis Studies With Apolipoprotein A-II Transgenic Mice Indicate a Role for HDLs in Adiposity and Insulin Resistance Diabetes, March 1, 2001; 50(3): 643 - 651. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |